News Daily News Everyone’s Glum About RECOVER IV: Where Shock Care Heads Next Is Unclear Caitlin E. Cox July 03, 2024
News Daily News RECOVER IV Impella Trial Halted in the Wake of DanGer Shock Caitlin E. Cox June 18, 2024
Presentation TCT 2023 Pro: Most Patients With AMI Cardiogenic Shock Should Get MCS (Randomization Is Unethical) Presenter: William O'Neill October 24, 2023
Presentation Complex Coronary Cases 2023 National Cardiogenic Shock Initiative Presenter: William O’Neill June 15, 2023
Presentation Miami Valves 2023 Step - By - Step Approach to Cardiogenic Shock Presenter: William O’Neill February 04, 2023
News Daily News SCAI SHOCK: Update Refines Cardiogenic Shock Classification Caitlin E. Cox January 31, 2022
News Conference News TCT 2021 Cardiogenic Shock: SCAI Categories Get a Rethink as Research Rolls On Caitlin E. Cox November 09, 2021
Presentation TCT 2021 Pro: Should Multivessel PCI Be Performed Acutely in All or Many Patients With Cardiogenic Shock? Presenter: William W. O'Neill November 05, 2021
Presentation TCT 2021 Ongoing/Planned Cardiogenic Shock Trials in the US Presenter: William O'Neill November 05, 2021
Presentation TCT 2021 Real World Evidence leading to RECOVER IV Presenter: William O'Neill November 04, 2021
News Daily News Cardiogenic Shock Teams May Lower Mortality in Cardiac ICUs Todd Neale September 21, 2021
News Conference News TCT 2020 Trickier Patients, Fewer Adverse Events in High-risk PCI: Impella PROTECT III Registry Caitlin E. Cox October 18, 2020
News Conference News TCT 2019 NCSI Strategy for Acute MI Cardiogenic Shock Reaps Better Survival Caitlin E. Cox October 10, 2019
Presentation TCT 2019 Acute Cardiogenic Shock: The Number One Unresolved Challenge in Cardiovascular Disease Presenter: William O'Neill September 27, 2019
Presentation CHIP Seattle 2019 All Patients With Ami Cardiogenic Shock Should Receive Advanced Mechanical Circulatory Support Presenter: William W. O’Neill August 02, 2019
News Industry News FDA Approves Initiation of STEMI DTU Pivotal Randomized Controlled Trial May 02, 2019
News Daily News More Registry Data Show No Survival Advantage for Impella in Acute MI With Cardiogenic Shock Caitlin E. Cox December 11, 2018
Presentation TCT 2018 AMICS: Predictors of Survival in Patients With Acute Myocardial Infarction and Cardiogenic Shock Supported With a Percutaneous Left Ventricular Assist Device Presenter: Jonathan M. Hill, E. Magnus Ohman, William W. O'Neill September 22, 2018